Lobbying Filing Details

Total Spending

$1,150,000

Activities

5

Lobbyists

5

Gov't Entities

24

Filing Information
Filing UUID:
a87602b8-2e62-4e4c-8a09-8ff30482111f
Type:
Q4 - 4th Quarter - Report
Period:
2025 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2026 at 9:15 PM
Income:
$0
Expenses:
$1,150,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
ASSOCIATION FOR ACCESSIBLE MEDICINES

Association representing the interests of the generic pharmaceutical industry.

Washington, District of Columbia
Client
ASSOCIATION FOR ACCESSIBLE MEDICINES
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Budget/Appropriations

FDA Funding.

Lobbyists (1)
  • MARK RATNER
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Copyright/Patent/Trademark

H.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. H.R.3152/S.1546: Patent Eligibility Restoration Act of 2025. H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act. S.1041: Affordable Prescriptions for Patients Act. S.1096: Preserve Access to Affordable Generics and Biosimilars Act. H.R.6485/S.43: Skinny Labels, Big Savings Act. S.1040: Drug Competition Enhancement Act. PTO rulemaking on inter partes review. H.R.5811: Restoring Americas Leadership in Innovation Act of 2025 (RALIA Act).

Lobbyists (5)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
Government Entities (7)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 2 more
Activity 3
Medicare/Medicaid

Medicare Part D Reform. Medicaid Rebate Penalty. Medicare/Medicaid Inflation Penalties. Medicare Conditions of Participation.

Lobbyists (4)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • MARK RATNER
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Pharmacy

Prescription Drug Costs. H.R.1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. S.1302: Increasing Transparency in Generic Drug Applications Act. Generic Drug Reporting Requirement Language in the Senate NDAA, S.2296 - National Defense Authorization Act for Fiscal Year 2026. S.1071 - National Defense Authorization Act for Fiscal Year 2026. Drug Shortages. H.R.5526/S.1954: Biosimilar Red Tape Elimination Act (BRTEA). H.R.1051: To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes. American Relief Act, 2025 (PL. No: 118-158) as it relates to Patent Thickets and Q1/Q2. H.R.4191/S.1784: Mapping Americas Pharmaceutical Supply (MAPS) Act. H.R.4132/S.2027: Prescription Information Modernization Act of 2025. Establishment Inspection Reports. S.1414/H.R.__: Expedited Access to Biosimilars Act. S.3469 - BIOSECURE Act of 2025. Quotas on Controlled Substances.

Lobbyists (5)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Food & Drug Administration (FDA)
Activity 5
Trade (domestic/foreign)

General Trade Issues. Drug Supply Chain. Country of Origin Labeling. Tariffs on Generic Medicines. Quotas on Generic Medicines. Increasing Domestic Production of Generics and Biosimilars. India Trade Negotiations. United States-Mexico-Canada Agreement.

Lobbyists (5)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • U.S. Trade Representative (USTR)
  • Commerce, Dept of (DOC)
  • ... and 1 more

Source: LDA.gov, data retrieved November 3, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.